HEM Pharma Inc.

₩22,600As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:376270Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (108.52%)
Pharmaceutical Preparations
Beta (5Y) 0.94
PE TTM —
TSR TTM (21.12%)
Mkt cap ₩162.9B
ROIC (31.04%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩27,884
23.38%
(57.51%)
Hold 8|9|10|3|4
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
429.66
461.08
486.54
538.38
(7.54%)
(1.84%)
4.42%
21.17%
Revenue₩B
12.03
12.36
12.68
12.94
5.85%
9.85%
8.74%
11.47%
Peers (US$120.1M)
Cap (US$)
PE
121.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.645
0.077
0.063
EBIT/Intx
1.850
0.035
0.041
Own earn%
23.52
47.69
19.95
Sh yield%
38.59
29.09
29.84
Owners
Insiders/Inst%
12.84
48.93
Short interest%
2.37
SBC / revenue%
5.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
25–31
$1 testx
−0.1
Incr. ROIC%
2